Financial Management Professionals’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.4K | Sell |
367
-605
| -62% | -$50.2K | ﹤0.01% | 338 |
|
2025
Q1 | $78.8K | Sell |
972
-83
| -8% | -$6.73K | 0.01% | 205 |
|
2024
Q4 | $95K | Sell |
1,055
-6
| -0.6% | -$540 | 0.01% | 198 |
|
2024
Q3 | $105K | Hold |
1,061
| – | – | 0.01% | 191 |
|
2024
Q2 | $98K | Hold |
1,061
| – | – | 0.01% | 196 |
|
2024
Q1 | $101K | Buy |
1,061
+271
| +34% | +$25.8K | 0.01% | 198 |
|
2023
Q4 | $71K | Sell |
790
-12
| -1% | -$1.08K | 0.01% | 221 |
|
2023
Q3 | $59K | Hold |
802
| – | – | 0.01% | 232 |
|
2023
Q2 | $67K | Sell |
802
-949
| -54% | -$79.3K | 0.01% | 234 |
|
2023
Q1 | $133K | Buy |
1,751
+1,342
| +328% | +$102K | 0.03% | 164 |
|
2022
Q4 | $34K | Sell |
409
-4
| -1% | -$333 | 0.01% | 275 |
|
2022
Q3 | $33K | Sell |
413
-252
| -38% | -$20.1K | 0.01% | 265 |
|
2022
Q2 | $49K | Sell |
665
-57
| -8% | -$4.2K | 0.01% | 229 |
|
2022
Q1 | $65K | Buy |
722
+252
| +54% | +$22.7K | 0.01% | 217 |
|
2021
Q4 | $53K | Hold |
470
| – | – | 0.01% | 246 |
|
2021
Q3 | $59K | Sell |
470
-3
| -0.6% | -$377 | 0.01% | 233 |
|
2021
Q2 | $64K | Buy |
473
+4
| +0.9% | +$541 | 0.02% | 211 |
|
2021
Q1 | $64K | Buy |
469
+8
| +2% | +$1.09K | 0.02% | 203 |
|
2020
Q4 | $65K | Sell |
461
-20
| -4% | -$2.82K | 0.02% | 188 |
|
2020
Q3 | $54K | Sell |
481
-102
| -17% | -$11.5K | 0.02% | 195 |
|
2020
Q2 | $65K | Buy |
+583
| New | +$65K | 0.02% | 164 |
|
2018
Q2 | – | Sell |
-35,392
| Closed | -$3.11M | – | 315 |
|
2018
Q1 | $3.11M | Buy |
35,392
+2,434
| +7% | +$214K | 1.61% | 14 |
|
2017
Q4 | $2.8M | Buy |
+32,958
| New | +$2.8M | 1.18% | 18 |
|